Aarti Pharmalabs Limited Cash Flow Reinvestment Rate
Aarti Pharmalabs Limited cash flow reinvestment rate. Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs375.40 Million. Explore AARTIPHARM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aarti Pharmalabs Limited (2023–2025)
Cash flow reinvestment rate of Aarti Pharmalabs Limited from 2023 to 2025. Historical reinvestment intensity for Aarti Pharmalabs Limited across 3 annual periods. Explore AARTIPHARM capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Aarti Pharmalabs Limited Cash Flow Reinvestment Rate by Year (2023–2025)
Aarti Pharmalabs Limited cash flow reinvestment rate by year from 2023 to 2025. Year-by-year capital reinvestment analysis for Aarti Pharmalabs Limited. For the full cash flow conversion analysis, see AARTIPHARM cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.21x | Rs4.02 Billion | Rs3.32 Billion | Rs4.02 Billion | ▲ +32.0% |
| 2024 | 0.92x | Rs1.99 Billion | Rs2.16 Billion | Rs1.99 Billion | ▼ -12.9% |
| 2023 | 1.06x | Rs2.77 Billion | Rs2.63 Billion | Rs1.20 Billion | — |